Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailPigeon circovirus: baculovirus expression of the capsid protein gene, specific antibody and viral load measured by real time polymerase chain reaction
Duchatel, Jean-Pierre ULg; Todd, D.; Smyth, J. et al

in Israel Journal of Veterinary Medicine (2011), 66(1), 26-31

Detailed reference viewed: 75 (2 ULg)
See detailPigeon Mara
Tomasovic, Dick ULg

in Aubenas, Jacqueline (Ed.) Dic Doc: Dictionnaire des Documentaristes belges (1999)

Detailed reference viewed: 23 (1 ULg)
Full Text
Peer Reviewed
See detailPigments from the Middle Palaeolithic levels of Es-Skhul (Mount Carmel, Israel)
d'Errico, Francesco; Salomon, Hélène ULg; Vignaud, Colette et al

in Journal of Archaeological Science (2010), 37

Discovery of pigments at Middle Palaeolithic sites is of interest in the context of the ongoing debate about the tempo and mode of the emergence of modern human behaviour. Here we analyse four previously ... [more ▼]

Discovery of pigments at Middle Palaeolithic sites is of interest in the context of the ongoing debate about the tempo and mode of the emergence of modern human behaviour. Here we analyse four previously undescribed fragments of pigmental material from Es-Skhul shelter, layer B, Israel, McCown excavations, identified at the Department of Palaeontology, Natural History Museum, London. One of them is still partially embedded in the hard breccia characteristic of this layer. Inspection of breccia fragments from layer B has led to the identification of small pieces of red and orange pigmental material still enclosed in large clasts, further corroborating the attribution of the larger pieces analysed in this study to layer B. The four objects are studied using optical microscopy, Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), Energy Dispersive X-ray (EDX), X-ray micro-diffraction (m-XRD), Particle-Induced X-Ray Emission Spectrometry (PIXE), and Proton-Induced Gamma-ray Emission (PIGE). The specimens display various hues of yellow, orange, red, and one of them presents a gradual variation of shade from yellow to dark orange. SEM/EDX analysis identifies two specimens (Skhul 1 and 2) as being composed of iron-rich calcium phosphate, the third (Skhul 3) of potassium-rich clay with titanium-rich iron oxide inclusions, and the fourth (Skhul 4) of pure iron oxide crystals. TEM/ EDX and m-XRD analysis demonstrate that three pieces (Skhul 1, 2 and 4) were heated to at least 300 C, a process that has partially or completely dehydrated goethite into haematite and changed their pristine yellow colour into orange or red. Skhul 3 shows no sign of heating, suggesting that its haematite content has a geological origin. The different mineral composition of the pieces suggests that they must come from a variety of sources. This implies that the associated collection strategies included the selection of materials that differed not only with respect to colour but also with respect to other physical and chemical properties. Although no formal proof exists that these lumps of pigmental material were deliberately heated, results obtained are consistent with this explanation. [less ▲]

Detailed reference viewed: 53 (4 ULg)
Peer Reviewed
See detailThe pigs as an experimental and teaching model in interventionnal radiology
Ghysels; Devière; Brisbois et al

Conference (1997)

Detailed reference viewed: 2 (0 ULg)
See detailPigtailed macaques (Macaca nemestrina leonina): the pest and the gardener
Huynen, Marie-Claude ULg; Albert, Aurélie; Savini, Tommaso ULg

Conference (2010, July)

Detailed reference viewed: 7 (0 ULg)
See detailPiles à combustible : situation actuelle et perspectives
Job, Nathalie ULg

Conference (2010, May 27)

Detailed reference viewed: 20 (5 ULg)
See detailPiles à combustible: vers une solution économiquement viable
Job, Nathalie ULg

Conference given outside the academic context (2013)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailPilgrimage Certificates from the Mamluk Period: New Data
Bauden, Frédéric ULg

in Bulletin of the School of Oriental and African Studies (in press)

Detailed reference viewed: 31 (8 ULg)
Full Text
Peer Reviewed
See detailPilgrimage out of Dispossession
Pagnoulle, Christine ULg

in Commonwealth : Essays and Studies (1994), 17(1), 100-106

Goodison's poems testify to her proud self-assertion, both as woman and as a descendant of African slaves.

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailPili genes pattern in Group B streptococci from newborn infections and pregnant women in Europe (DEVANI Project)
Imperi, Monica; Rinaudo, Daniela; Creti, Roberta et al

Poster (2011, September)

Objectives Evaluation of the presence and expression of genes coding for pili in a collection of group B streptococcci (GBS) isolated from newborn infection and pregnant women in the course of the DEVANI ... [more ▼]

Objectives Evaluation of the presence and expression of genes coding for pili in a collection of group B streptococcci (GBS) isolated from newborn infection and pregnant women in the course of the DEVANI (Design of a Vaccine Against Neonatal Infection) project. Methods GBS isolates from pregnant women (PW) and cases of newborn infection (NI) were collected in 8 European countries (Belgium, Bulgaria, Czech Republic, Denmark, Germany, Italy, Spain, United Kingdom) during 2009/10 under the auspices of DEVANI. Total no. of strains examined was 1078 and 192 from PW and NI, respectively. Isolates were screened by multiplex PCR and FACS analysis to evaluate respectively gene presence and surface-exposure of pili. Results The most common gene patterns found were PI-2a alone, PI 1+2a and PI 1+2b, while the PI-2b gene alone was very rare. The most prominent result was that a majority of isolates from NI carried the PI-1+2b gene pattern, while the most common pattern among PW was PI-1+2a. Most of analyzed strains express at least one pilus on their surface. Conclusions All isolates contained at least one gene coding for pili. When present pili 2a and 2b were highly surface exposed. [less ▲]

Detailed reference viewed: 39 (2 ULg)
Full Text
Peer Reviewed
See detailLes piliers en céramique.
Mainjot, Amélie ULg; Legros, Caroline ULg; Van Heusden, Alain ULg

in Revue Belge de Médecine Dentaire = Belgisch Tijdschrift voor Tandheelkunde (2006), 61(2), 96-108

As a result of ceramics and all-ceram technologies development esthetic inlay core and abutments flooded the market. Their tooth-colored appearance enhances restoration biomimetism principally on the ... [more ▼]

As a result of ceramics and all-ceram technologies development esthetic inlay core and abutments flooded the market. Their tooth-colored appearance enhances restoration biomimetism principally on the marginal gingiva area. This article reviews indications and types of cores designed for natural teeth and implants. [less ▲]

Detailed reference viewed: 28 (2 ULg)
Full Text
See detailLe pilomatricome unique ou multifocal et son pendant malin.
Reginster, Marie-Annick ULg; Quatresooz, Pascale ULg; Franchimont, Claudine ULg et al

in Dermatologie Actualité (2010), 121

Detailed reference viewed: 59 (1 ULg)
See detailPilootproject : ontslagmanagement in Belgische ziekenhuizen. [Pilot study : discharge management in Belgian hospitals]. Final report, 2000
Abraham, I; Bollen, S; de Froidmont, C et al

Report (2000)

Detailed reference viewed: 18 (3 ULg)
Full Text
Peer Reviewed
See detailA pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations
Messin, R.; Fenyvesi, T.; Carreer-Bruhwyler, F. et al

in European Journal of Clinical Pharmacology (2003), 59(3), 227-232

Objectives. A new once-a-day (o.a.d.) formulation of molsidomine (16 mg) was evaluated in patients with stable angina pectoris. The aims were to characterize its pharmacokinetics after a single dose, to ... [more ▼]

Objectives. A new once-a-day (o.a.d.) formulation of molsidomine (16 mg) was evaluated in patients with stable angina pectoris. The aims were to characterize its pharmacokinetics after a single dose, to demonstrate its clinical efficacy and safety versus placebo and to investigate correlations between pharmacokinetics and pharmacodynamics. Methods. Forty-two patients were recruited in a double-blind, crossover, randomized placebo-controlled trial. The pharmacokinetics of molsidomine and SIN-1, its active metabolite, were determined at specific time points (3, 6, 10, 14, 18, 22 and 24 h) after the administration of a single dose of molsidomine 16 mg o.a.d. in all patients distributed into seven groups. Twenty-eight of these 42 patients showed a positive baseline cycloergometric exercise test response during the run-in placebo period and were used to compare the efficacy of molsidomine to placebo. Relationships between plasma concentration in molsidomine or SIN-1 and ischemic threshold were assessed in 16 of the 28 patients with a positive exercise test at baseline. Indeed, the censored variable ischemia-limited tolerance to exercise could not be evaluated in those patients who did not show exercise-induced ischemia anymore under molsidomine 16 mg o.a.d. Pharmacokinetic-pharmacodynamic relationships were evaluated using regression models and correlation coefficients. Results. The highest average concentration in molsidomine and SIN-1 occurred after 6 h, then a plateau of 15-20 ng/ml molsidomine and 0.8-3.0 ng/ml SIN-1 was maintained for at least 8 h and the mean residual molsidomine concentration 24 h post-drug intake was around 8 ng/ml, still in the effective range of 5-10 ng/ml. A significant increase in total workload (+52 W min, P=0.009), total exercise time (+32 s, P=0.003) and time to angina (+25 s, P=0.016) was measured with molsidomine 16 mg o.a.d. relative to placebo. Using linear regression, significant correlation coefficients were determined between molsidomine plasma concentrations (but not SIN-1) and exercise test improvements (r=0.827, P<0.001 for the total workload; r=0.772, P<0.001 for the total exercise time; and r=0.566, P=0.028 for the time to 1 mm ST-segment depression). Conclusion. The pharmacokinetics of molsidomine 16 mg in patients with stable angina pectoris is compatible with a o.a.d. dosage regimen. This o.a.d. formulation is effective and well-tolerated, providing a 24-h therapeutic control of myocardial ischemia. A positive and significant linear relationship between molsidomine plasma concentration and the increase in exercise tolerance was observed. [less ▲]

Detailed reference viewed: 38 (4 ULg)